Insufficient scRNA-seq data for expression of VWCE at single-cell level.
Insufficient scRNA-seq data for expression of VWCE at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| ovary | 100% | 2292.21 | 180 / 180 | 89% | 9.88 | 383 / 430 |
| brain | 91% | 278.34 | 2395 / 2642 | 98% | 7.90 | 693 / 705 |
| liver | 100% | 2262.85 | 226 / 226 | 79% | 11.51 | 322 / 406 |
| thymus | 97% | 271.54 | 634 / 653 | 66% | 6.31 | 397 / 605 |
| kidney | 75% | 130.04 | 67 / 89 | 76% | 7.36 | 681 / 901 |
| adrenal gland | 99% | 297.10 | 256 / 258 | 41% | 1.32 | 94 / 230 |
| uterus | 96% | 450.32 | 163 / 170 | 38% | 2.81 | 174 / 459 |
| bladder | 90% | 137.14 | 19 / 21 | 33% | 1.00 | 167 / 504 |
| skin | 90% | 259.75 | 1634 / 1809 | 32% | 0.93 | 152 / 472 |
| prostate | 98% | 362.97 | 240 / 245 | 18% | 0.34 | 91 / 502 |
| breast | 100% | 484.22 | 457 / 459 | 14% | 0.29 | 161 / 1118 |
| adipose | 100% | 676.18 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 100% | 3.35 | 1 / 1 |
| esophagus | 74% | 121.84 | 1073 / 1445 | 26% | 0.81 | 47 / 183 |
| stomach | 67% | 162.93 | 241 / 359 | 33% | 1.20 | 93 / 286 |
| intestine | 73% | 128.04 | 709 / 966 | 25% | 0.94 | 130 / 527 |
| peripheral blood | 93% | 569.00 | 864 / 929 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 91% | 5.40 | 73 / 80 |
| lymph node | 0% | 0 | 0 / 0 | 83% | 4.84 | 24 / 29 |
| spleen | 82% | 106.10 | 198 / 241 | 0% | 0 | 0 / 0 |
| lung | 56% | 84.63 | 322 / 578 | 24% | 0.62 | 279 / 1155 |
| blood vessel | 79% | 149.64 | 1050 / 1335 | 0% | 0 | 0 / 0 |
| heart | 76% | 125.84 | 652 / 861 | 0% | 0 | 0 / 0 |
| muscle | 72% | 144.56 | 579 / 803 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 33% | 1.17 | 15 / 45 |
| pancreas | 15% | 15.02 | 48 / 328 | 19% | 0.44 | 33 / 178 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0098586 | Biological process | cellular response to virus |
| GO_0005576 | Cellular component | extracellular region |
| GO_0005737 | Cellular component | cytoplasm |
| GO_0005509 | Molecular function | calcium ion binding |
| GO_0005515 | Molecular function | protein binding |
| GO_0003674 | Molecular function | molecular_function |
| Gene name | VWCE |
| Protein name | von Willebrand factor C and EGF domain-containing protein (HBV X protein up-regulated gene 11 protein) (HBxAg up-regulated gene 11 protein) cDNA FLJ51386 (von Willebrand factor C and EGF domains) cDNA FLJ58937 (von Willebrand factor C and EGF domains) |
| Synonyms | URG11 |
| Description | FUNCTION: May be a regulatory element in the beta-catenin signaling pathway and a target for chemoprevention of hapatocellular carcinoma. . |
| Accessions | ENST00000535599.1 B4DY31 B4DS56 Q96DN2 ENST00000301770.10 [Q96DN2-2] ENST00000335613.10 [Q96DN2-1] ENST00000535710.1 |